2675571
SCDGP · Clinical drug group packinfluenza A virus A/California/122/2022 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Michigan/01/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Product
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/California/122/2022 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Michigan/01/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Product?
influenza A virus A/California/122/2022 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Michigan/01/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Product is coded as 2675571 in RxNorm.
What is RxNorm code 2675571?
2675571 is the RxNorm identifier for influenza A virus A/California/122/2022 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Michigan/01/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Product. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2675571?
2675571 is a SCDGP (Clinical drug group pack) in RxNorm.
What is the UMLS mapping for 2675571?
2675571 maps to UMLS C5888474.